Acasti Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Acasti Pharma has a total shareholder equity of $61.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $73.3M and $11.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$23.01m |
Equity | US$61.74m |
Total liabilities | US$11.56m |
Total assets | US$73.30m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A1P0's short term assets ($24.0M) exceed its short term liabilities ($1.7M).
Long Term Liabilities: A1P0's short term assets ($24.0M) exceed its long term liabilities ($9.9M).
Debt to Equity History and Analysis
Debt Level: A1P0 is debt free.
Reducing Debt: A1P0 has no debt compared to 5 years ago when its debt to equity ratio was 12.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A1P0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A1P0 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 5.8% each year.